Herpes Zoster (Shingles) in the Practice of a Primary Care Pediatrician
https://doi.org/10.22627/2072-8107-2026-25-2-63-66
Abstract
Reactivation of the varicella-zoster virus (VZV) in neurons of the trigeminal and spinal ganglia causes a disease known as herpes zoster (shingles, ZH). The disease is rare in childhood and is mainly associated with immunosuppressive conditions. This article presents a case of early diagnosis of ZH in an immunocompetent 7year-old child, which developed due to predisposing factors. Prescribing antiviral therapy at the first sign of a rash allowed for rapid containment of the infection and prevention of complications. Physicians must remain vigilant for herpes zoster to effectively limit the epidemic. This clinical case once again highlights the importance of routine varicella vaccination not only to prevent primary infection but also the risk of developing herpes zoster later.
About the Authors
T. M. Chernova
Saint Petersburg State Pediatric Medical University Ministry of Health of the Russian Federation
Russian Federation
Russian Federation
Saint Petersburg
V. N. Timchenko
Saint Petersburg State Pediatric Medical University Ministry of Health of the Russian Federation
Russian Federation
Russian Federation
Saint Petersburg
E. A. Elkhawaga
Saint Petersburg State Pediatric Medical University Ministry of Health of the Russian Federation
Russian Federation
Russian Federation
Saint Petersburg
O. V. Bulina
Saint Petersburg State Pediatric Medical University Ministry of Health of the Russian Federation
Russian Federation
Russian Federation
Saint Petersburg
A. Yu. Tokarskaya
Saint Petersburg City Polyclinic No. 44
Russian Federation
Russian Federation
Saint Petersburg
References
1. Xia Y, Zhang X, Zhang L, Fu C. Efficacy, effectiveness, and safety of herpes zoster vaccine in the immunocompetent and immunocompromised subjects: a systematic review and network meta-analysis. Front Immunol. 2022;13:978203. doi: 10.3389/fimmu.2022.978203
2. Nair PA, Patel BC. Herpes zoster. In: Shumway K, editor. StatPearls. Treasure Island, FL: StatPearls; 2024. Available at: https://www.ncbi.nlm.nih.gov/books/NBK441824/
3. Shishov AS, Shakaryan AK, Belyaletdinova IKh, Mitrofanova IV. Clinical features of herpes zoster in infants. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2019;119(7, issue 2):67—73. doi: 10.17116/jnevro201911907267 (In Russ).
4. Pietrzak MK, Pokorska-Śpiewak M. Shingles in children. Pediatr Infect Dis J. 2024;43:e275—e277. doi: 10.1097/INF.0000000000004404
5. Prikhodchenko NG. Varicella zoster virus infection: clinical features, manifestations, complications and prevention possibilities. Therapeutic Archive. 2021;93(11):1401—1406. doi: 10.26442/00403660.2021.11.201192 (In Russ).
6. Zhang S, Kim VHD, Grunebaum E. Pediatric herpes zoster: should I be concerned for immunodeficiency? A review. Front Pediatr. 2025;13:1561339. doi: 10.3389/fped.2025.1561339
7. Laing KJ, Ouwendijk WJD, Koelle DM, Verjans GMGM. Immunobiology of varicella-zoster virus infection. J Infect Dis. 2018;218(suppl_2):68—74. doi: 10.1093/infdis/jiy403
8. Patil A, Goldust M, Wollina U. Herpes zoster: a review of clinical manifestations and management. Viruses. 2022;14:192. doi: 10.3390/v14020192
9. Latif TM, Hasan AI, Muhammad KA. Herpes zoster in children: A prospective study. J Pak Assoc Dermatol. 2023;33(3):813—816.
10. Bieńkowski C, Talarek E, Pokorska-Śpiewak M. The clinical course of herpes zoster is similar in immunocompetent and immunocompromised paediatric patients. J Paediatr Child Health. 2023;59(10):1112—1114. doi: 10.1111/jpc.16461
11. Kanamori K, Shoji K, Kinoshita N, Ishiguro A, Miyairi I. Complications of herpes zoster in children. Pediatr Int. 2019;61(12):1216—1220. doi: 10.1111/ped.14025
12. Gündoğdu M, Erden N, Karagun E, AŞF A, Vural S. Annual pattern and clinical characteristics of herpes zoster in immunocompetent children in a rural area. Dermatol Ther. 2021;34(1):e14570. doi: 10.1111/dth.14570
13. Raquet B, Murphy KN, Lawson L. Pediatric Herpes Zoster in a 10-Year-Old Boy With Delayed Immunizations: A Case Report. Cureus. 2025;17(3): e80787. doi: 10.7759/cureus.80787
14. Vyal'tseva YuV, Rymarenko NV, Chernyaeva ES. Herpes zoster in children in the post-COVID period: a clinical case analysis. Journal of Infectology. 2025;17(3):169—174. doi: 10.22625/2072-6732-2025-17-3-169-174 (In Russ).
15. Titov LP, Kiril'chik EYu, Kanashkova TA. Features of the structure, development and functioning of the immune system of the child's body. Medical News. 2009;5. Available at: https://www.mednovosti.by/journal.aspx?article = 4299 (In Russ).
16. Saburova OA, Sobchak DM, Otmakhova KA. Study of T-cell immunity, interferonogenesis, inflammatory mediators in children with Varicella zoster virus infection. Children's Infections. 2022;21(1):41—44. doi: 10.22627/2072-8107-2022-21-1-41-44 (In Russ).
17. Timchenko VN, Pavlova EB, Mikhailov IB, Khmilevskaya SA. Diagnosis and treatment of childhood infections (Handbook). Saint Petersburg: SpetsLit; 2025. 463 p. (In Russ).
18. Herpes zoster. Clinical recommendations. 2016. Available at: https://medi.ru/klinicheskie-rekomendatsii/gerpes-opoyasyvayuschij_13968 (In Russ).
19. Prevention of chickenpox and shingles. SanPiN 3.3686-21. «Sanitary and epidemiological requirements for the prevention of infectious diseases». (In Russ).
20. Janniger CK, Elston JS, Hospenthal DR, Moon JE. Herpes Zoster Treatment & Management. Medscape. 2025 Mar 11. Available at: https://emedicine.medscape.com/article/1132465-treatment
21. Ignatovsky AV. Herpes zoster — modern approaches to diagnosis and treatment. Doctor. 2022;33(10):24—32. doi: 10.29296/25877305-2022-10-04 (In Russ).
22. Acyclovir. Instructions for use. Available at: https://www.vidal.ru/drugs/aciclovir29945 (In Russ).
Review
For citations:
Chernova T.M., Timchenko V.N., Elkhawaga E.A., Bulina O.V., Tokarskaya A.Yu. Herpes Zoster (Shingles) in the Practice of a Primary Care Pediatrician. CHILDREN INFECTIONS. 2026;25(2):63-66. (In Russ.) https://doi.org/10.22627/2072-8107-2026-25-2-63-66
Views:
20
JATS XML
Email this article 